MAZE - Maze Therapeutics, Inc.
25.81
-0.200 -0.775%
Share volume: 503,984
Last Updated: 04-24-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.22%
PREVIOUS CLOSE
CHG
CHG%
$26.01
-0.20
-0.01%
View ratios
| Fiscal Date | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-14-2025 | 11-06-2025 | 03-25-2026 | |
| Assets | ||||
| Total Assets | 332.840 M | 422.058 M | 397.127 M | |
| Current Assets | 299.707 M | 391.302 M | 349.717 M | |
| Inventories | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 67.162 M | 152.670 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | |
| Current Cash | 294.374 M | 316.773 M | 189.247 M | |
| Total Non-current Assets | 0.000 | 0.000 | 18.114 M | |
| Property Plant Equipment | 6.314 M | 5.538 M | 5.044 M | |
| Other Assets | 26.819 M | 25.218 M | 42.366 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||
| Total Liabilities and shareholders’ equity | 332.840 M | 422.058 M | 397.127 M | |
| Total liabilities | 40.772 M | 42.622 M | 42.161 M | |
| Total current liabilities | 18.617 M | 22.112 M | 22.556 M | |
| Accounts Payable | 2.404 M | 2.918 M | 1.794 M | |
| Other liabilities | 22.155 M | 20.510 M | 19.605 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 22.155 M | 20.510 M | 19.605 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 292.068 M | 379.436 M | 354.966 M | |
| Common stock | 683.281 M | 834.346 M | 844.403 M | |
| Retained earnings | -391.213 M | -454.979 M | -489.547 M |